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 During the last years, molecular karyotyping by ei-
ther array-CGH or genomic profiling using SNP arrays 
has not only increased the diagnostic outcome in pa-
tients with intellectual disability harboring individual 
small chromosomal aberrations [de Vries et al., 2005; 
Hoyer et al., 2007] but also enabled the identification of 
several novel common microdeletion syndromes as re-
viewed by Slavotinek [2008]. Furthermore, it has also 
been proven to be a suitable method to identify novel 
disease-causing genes by initially identifying small aber-
rations affecting only one or few genes thus pointing to 
candidate genes in which subsequently mutations are 
identified in patients with similar phenotypes but with-
out copy number variants. This strategy has been suc-
cessful for well-known syndromic disorders such as au-
tosomal-dominant CHARGE syndrome (MIM#214800) 
[Vissers et al., 2004] or autosomal recessive Peters Plus 
syndrome (MIM#261540) [Lesnik Oberstein et al., 2006] 
but also for relatively unknown entities such as Pitt-Hop-
kins syndrome (MIM#610954) [Amiel et al., 2007; Zwei-
er et al., 2007], a recognizable severe intellectual disabil-
ity syndrome that only came to a broad clinical aware-
ness after identification of the underlying gene defect. 
Further examples are the identification of causative 
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 Abstract 
 Using high-resolution molecular karyotyping with SNP ar-
rays to identify candidate genes for etiologically unex-
plained intellectual disability, we identified a 32-kb de novo 
in-frame deletion of the C-terminal helicase domain of the 
 SMARCA2 gene in a patient with severe intellectual disability, 
epilepsy, sparse hair, prominent joints, and distinct facial 
anomalies. Sequencing of the gene in patients with a similar 
phenotype revealed de novo missense mutations in this do-
main in 2 further patients, pointing to a crucial role of the 
SMARCA2 C-terminal helicase domain. The clinical features 
observed in all 3 patients are typical of Nicolaides-Baraitser 
syndrome, an only rarely reported syndrome with mainly 
moderate to severe intellectual disability. Notably, one of 
our patients with a p.Gly1132Asp mutation showed typical 
morphological features but an exceptional good develop-
ment with borderline overall IQ and learning difficulties, 
thus expanding the phenotypic spectrum of Nicolaides-
Baraitser syndrome.  Copyright © 2012 S. Karger AG, Basel 
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genes for an epileptic encephalopathy [Saitsu et al., 2008] 
or non-specific severe intellectual disability [Zweier et 
al., 2010].
 In our systematic endeavor to identify new disease 
genes in patients with intellectual disability by molecular 
karyotyping, we identified a small de novo deletion with-
in the  SMARCA2 gene in a patient with short stature, in-
tellectual disability, and distinct anomalies resembling 
Nicolaides-Baraitser syndrome (MIM ID %601358). By 
sequencing of patients with a similar phenotype, we ad-
ditionally revealed missense mutations in the C-terminal 
helicase domain in this gene in 2 further patients. Our 
findings concur with another recent report identifying 
 SMARCA2  as the gene underlying Nicolaides-Baraitser 
syndrome [Van Houdt et al., 2011].
 Case Reports 
 Patient 1 
 Patient 1 ( fig. 1 A–F), the third child of healthy, non-consan-
guineous parents, was born after an uneventful pregnancy at 
week 38 by cesarean section. His birth weight was 3,145 g (25th 
centile), his length was 52 cm (50th centile), and his head circum-
ference was 35 cm (25th centile). The neonatal period was compli-
cated by muscular hypotonia, feeding difficulties, and failure to 
thrive. Bilateral inguinal hernias were operated. Furthermore, 
mild aortic coarctation and cryptorchism were diagnosed. Devel-
opmental motor milestones were delayed with a sitting age of 13 
months and a walking age of 30 months. At the age of 3 years and 
4 months seizures occurred and were treated with valproate.
 The patient was last seen at the age of 3 years and 7 months. 
He had short stature and microcephaly with a body height of 85 
cm ( ! 3rd centile), weight of 11 kg ( ! 3rd centile), and head circum-
ference of 47.5 cm ( ! 3rd centile). At this time he presented with 
severe intellectual disability and could not speak any word. Be-
A B C D E F
G H I J K L
M N O P Q R
 Fig. 1. Phenotypes of 3 patients with defects in  SMARCA2 .  A ,  B Patient 1 at the age of 21 months.  C– F Facial 
gestalt, hand and foot of patient 1 at the age of 3 years and 7 months.  G ,  H Patient 2 at the age of 3 years and
6 months.  I– L Facial gestalt, hand and foot of patient 2 at the age of 8 years.  M– R Scalp hair, knees, hand from 
in- and outside, and foot of patient 3 at the age of 9 years. 
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havioral anomalies were short attention span and little social in-
teraction with reduced eye contact. The boy had sparse hair, ec-
zema of the skin, and facial dysmorphism with a high forehead, 
arched and medially sparse eyebrows, long eyelashes, wide and 
downslanting palpebral fissures, wrinkled skin below the eyes, 
flat and sagging malar regions, a short nose with upturned tip, a 
long philtrum, a thin upper vermillion, a full everted lower ver-
million, and mildly posteriorly rotated ears. Fingers and toes were 
long and slender with prominent interphalangeal joints. Knees 
appeared large and prominent, too. Minor other anomalies were 
single palmar creases, one café-au-lait spot, and sandal gaps.
 Metabolic screening as well as conventional karyotyping, I-
FISH testing for trisomy 8 mosaicism, and molecular karyotyping 
using an Affymetrix 6.0 Array on a 100-kb resolution revealed 
normal results.
 Patient 2 
 Patient 2 ( fig. 1 G–L) was the second child of healthy, non-con-
sanguineous parents and was born after an uneventful pregnancy 
at week 41. His weight was 2,890 g (10th centile), length was 49 cm 
(10th centile), and his head circumference was 32.5 cm ( ! 3rd cen-
tile). During the neonatal period, mild feeding difficulties oc-
curred, and a small preauricular tag was removed. Motor develop-
ment was normal with a sitting age of 6 months and a walking age 
of 13 months. The boy started to speak single words at the age
of 18 months, but further speech development ceased with the
occurrence of seizures. EEG examination showed generalized
irregular spike-wave complexes. The epilepsy was successfully 
treated with valproate and ethosuximide. Brain MRI at the age of 
2 years was normal. At the age of 3 years, the boy was little inter-
ested in other children and showed auto-aggressive tendencies. 
Constipation was observed for a certain period of time.
 The patient was last investigated at 8 years and 8 months and 
had mild short stature with a body height of 124.5 cm (3rd centile). 
His weight was 23.8 kg (3rd–10th centile), and he was microce-
phalic with a head circumference of 50.5 cm ( ! 3rd centile). At that 
time he was reported to have a vocabulary of more than 100 single 
words and the ability to rarely speak 2 word sentences. His speech 
appeared monosyllabic and slurred. In general, he had a happy 
and sociable personality. However, attention span was short, and 
he was very focused on routines. Formal diagnosis of autism was 
made, and standardized IQ testing was done but revealed no val-
id results. Facial dysmorphism included mildly downslanting pal-
pebral fissures, a thin upper lip, prominent incisors, mildly pos-
teriorly rotated ears, and a high and narrow palate. He had sparse 
and dry scalp hair with low-set posterior and anterior hairlines 
and hypertrichosis at his neck and upper back. Further anomalies 
were long fingers, long toes with prominent joints, and sandal 
gaps.
 Conventional karyotyping, testing for Fragile-X- and Angel-
man syndromes (incl.  UBE3A sequencing), sequencing of the 
 ARX gene, and molecular karyotyping with an Affymetrix 
Genechip 6.0 Mapping SNP Array revealed normal results.
 Patient 3 
 Patient 3 was the only child of healthy, non-consanguineous 
Caucasian parents aged 35 (mother) and 36 years (father) at birth. 
The boy was born at gestational week 37 after an uneventful preg-
nancy with mild maternal gestosis. Birth weight was 2,370 g (10th 
centile), birth length was 45 cm (10th centile), head circumference 
was 32 cm (10–25th centile), and Apgar-scores were 8-9-9. Follow-
ing an uneventful neonatal period, developmental milestones 
were mildly delayed. He was able to turn around from the back at 
the age of 7.5 months, to sit at the age of 10 months, and to walk 
independently at the age of 19 months. The mother reported that 
he suffered from instable feet joints and drooling in early infancy 
and that he could hardly speak until a very short lingual frenum 
was cut. At the age of about 18 months he had surgery for an in-
guinal hernia and cryptorchism. He also had an umbilical hernia 
and a severe hallux valgus on the right side which was treated sur-
gically. Formal IQ testing using the HAWIVA test at the age of 6 
years and 3 months revealed a verbal comprehension IQ of 82, a 
perceptual reasoning IQ of 73, a processing speed IQ of 54, and a 
total IQ of 74. Notably, he had profound problems with auditory 
memory and attention deficit. He also had significant gross and 
fine motor delay with ataxic gait. His personality was very com-
municative and sociable, but he had problems with following de-
mands and he had a short attention span. At the age of 7 years the 
boy developed seizures predominantly after falling asleep. Sei-
zures usually started with weeping followed by head and eye de-
viation to the left or the right, and postictally by alternating ipsi-
lateral hemiparesis. Other seizures were focal clonic or focal ton-
ic, sometimes with secondary generalization. EEG showed sharp 
waves with variable manifestation from the left or right central or 
centro-median regions. Seizures were successfully treated with 
Sultiam (sulfonamide). MRI imaging of the brain at the age of 8 
years was normal. An X-ray of the hand revealed a bone age retar-
dation of 2 years. Due to his social behavior and dissociated de-
velopmental profile with strong verbal abilities, Williams-Beuren 
syndrome was considered as a differential diagnosis.
 At the age of 9 years his weight was 20.6 kg (2nd centile), height 
was 124.5 cm (5th centile), and head circumference was 52 cm 
(23rd centile). Minor anomalies were a triangular face, thin, 
sparse and soft hair, dry and grayish skin with periorbital wrin-
kling and flat and sagging malar regions, long eyelashes, a narrow 
nasal bridge with a relatively bulbous nasal tip and a prominent 
columella, a relatively long and flat philtrum, a thin upper lip, 
mildly low-set, backwards rotated ears, a large but mildly retract-
ed chin, sandal gaps, and a relatively short, broad second toe. The 
proximal interphalangeal joints and knees were thick with wrin-
kling skin. Distal phalanges of fingers and toes were broad and 
some had fetal pads. Fingers showed multiple supernumerary in-
terphalangeal creases. The nails were reported to grow very slow-
ly and had to be cut only rarely. Apart from one tooth, which was 
lost recently, primary dentition was still present and the voice was 
high. The boy suffered from frequent respiratory infections and 
multiple warts. During consultation, the boy was very friendly, 
communicative and active, and the mother reported that he was 
able to read, but attention span was still low. He attended a school 
for children with special needs. The boy also suffered from ich-
thyosis which was, however, also present in his otherwise healthy 
father.
 Genetic testing included karyotyping, MLPA screening for 21 
microdeletions (P245 probemix, MRC-Holland), sister-chroma-
tid exchange testing, fragile X testing, and molecular karyotyping 
using an Affymetrix Cytogenetics 2.7M Array and revealed nor-
mal results. Maternal X-inactivation studies using the CAG repeat 
within exon 1 of the  AR gene revealed a skewing of 91% in periph-
eral blood.
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 Methods 
 Molecular Karyotyping 
 Molecular karyotyping in patient 1 and his parents was per-
formed with an Affymetrix 6.0 SNP Array (Affymetrix, Santa 
Clara, Calif., USA) in accordance with the supplier’s instructions. 
Copy number data were analysed with the Affymetrix Genotyp-
ing Console 3.0.2 software.
 MLPA 
 MLPA probes for exons 17–20, 26, and 27 of the  SMARCA2 
gene (covering both isoforms NM_003070.3 and NM_139045.2) 
were designed according to the instructions of MRC-Holland, 
and the reaction was performed using the SALSA MLPA reagents 
EK5 (MRC-Holland, Amsterdam, The Netherlands) in patient 1 
and his parents. The probemix contained additionally 6 internal 
control probes. Copy number values were calculated using values 
from 8 healthy control individuals and the Seqpilot software (JSI 
Medical Systems, Kippenheim, Germany). Probe sequences and 
conditions are available on request.
 Sequencing 
 DNA samples from peripheral blood were tested for  SMAR-
CA2 mutations by bidirectional direct sequencing of all coding 
exons 2–34 including intronic flanking regions (ABI BigDye Ter-
minator Sequencing Kit v.3; Applied Biosystems, Carlsbad, Calif., 
USA) using an automated capillary sequencer (ABI 3730; Applied 
Biosystems). Mutations were confirmed from an independent 
PCR and tested in the parents. Primer sequences and conditions 
are available on request. Sample mix-up in the patients with de 
novo mutations and their parents was excluded by using the Pow-
erplex 16 kit according to the supplier’s instructions (Promega, 
Madison, Wisc., USA).
 This study was approved by the ethics committees of the Med-
ical Faculty, University of Erlangen-Nuremberg and by the Kan-
tonale Ethikkommission of Zurich, and written consent was ob-
tained from parents or guardians of the patients.
 Results and Discussion 
 Initial diagnostic evaluation of the Affymetrix 6.0 Ar-
ray data in patient 1 with consideration of aberrations 
 1 100 kb showed normal results. Prompted by our finding 
of mutations in  ARID1B as a frequent cause of severe in-
tellectual disability [Hoyer et al., in press], we searched 
for smaller aberrations in related genes in our study group 
of 345 individuals. This approach indeed revealed in pa-
tient 1 a heterozygous 32-kb in-frame deletion within the 
 SMARCA2 gene affecting exons 20 to 26 coding for the 
C-terminal helicase domain (fig. 2A). These results were 
confirmed using MLPA probes located in 2 of the deleted 
and the flanking non-deleted exons each (data not 
shown). The deletion was excluded in both parents by ar-
ray analysis (fig. 2A) and by MLPA (data not shown). In 
addition, a copy number variant of  SMARCA2 was nei-
ther observed in the database of genomic variants nor in 
our 820 in-house control samples.
 SMARCA2 encodes Brahma (BRM), 1 of 2 mutually 
exclusive and specific ATPase subunits [Flowers et al., 
2009] of the SWI/SNF complex that was first identified in 
yeast and is highly conserved among eukaryotes [Kings-
ton and Narlikar, 1999]. ARID1B, haploinsufficiency of 
which was recently found to cause intellectual disability, 
is also a subunit of this complex [Halgren et al., 2011; Hoy-
er et al., in press]. The SWI/SNF ATP-dependent chroma-
tin remodeling complex regulates gene expression by us-
ing energy of ATP hydrolysis to alter chromatin structure 
around the regulated genes in order to facilitate access of 
other transcription factors [Peterson and Workman, 
2000].  SMARCA2 is highly expressed in differentiating 
cells [Kadam and Emerson, 2003] and plays an important 
role in neuronal development [Yoo and Crabtree, 2009]. 
Loss of BRM expression in different tumor cell lines might 
indicate that silencing of the SWI/SNF ATPases is in-
volved in the etiology of various tumors [Reisman et al., 
2009]. A role of SNPs in  SMARCA2 as susceptibility fac-
tors for schizophrenia is discussed due to respective asso-
ciation studies [Koga et al., 2009]. Furthermore,  Smarca2 
knockout mice showed impaired social interaction and 
prepulse inhibition [Koga et al., 2009].
 Therefore, we considered the intragenic  SMARCA2 
deletion in patient 1 to be causative for his disorder. Giv-
en the apparently distinct phenotype of the patient, we 
specifically searched for similar patients seen in the ge-
netic outpatient clinics in Erlangen and Zurich, respec-
tively. Two patients with strong morphological resem-
blance but milder intellectual deficit were identified. Se-
quencing of  SMARCA2 in these patients revealed the 
heterozygous missense mutation p.Ala1188Glu in exon 
25 in patient 2, and the heterozygous missense mutation 
p.Gly1132Asp in exon 24 in patient 3 (fig. 2B). In both pa-
tients, de novo occurrence was confirmed by excluding 
the respective mutation in the parents, and sampling er-
rors were excluded by confirming probe identities within 
the families. Interestingly, both missense mutations were 
located at highly conserved amino acid positions in the 
C-terminal helicase domain of the SMARCA2 protein. 
This domain was also affected by the predicted in-frame 
deletion in patient 1 (fig. 2C). Therefore, our findings in-
dicate that loss of, impaired, or altered function of the C-
terminal helicase domain might underlie the common 
phenotypic consequences in these patients.
 The striking clinical resemblance of the 3 patients in-
cludes sparse hair, borderline or mild short stature, epi-
lepsy, and behavioral anomalies like autistic traits and 
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short attention span. All 3 patients showed a distinct fa-
cial gestalt with a triangular shaped face, wide, downslant-
ing palpebral fissures, a long philtrum, a thin upper lip, 
and a full or everted lower lip. Various other anomalies 
were microcephaly, skin anomalies such as eczema or 
wrinkling, hernias, long fingers and toes with prominent 
interphalangeal joints and broad distal phalanges, and 
minor congenital heart defects.
 Apart from the borderline intelligence in patient 3, all 
clinical features and the facial dysmorphism of our pa-
tients with  SMARCA2 defects are characteristic for Nico-
laides-Baraitser syndrome ( table 1 ). After the initial de-
scription in 1993 [Nicolaides and Baraitser, 1993], this 
disorder was only very rarely reported until Sousa et al. 
[2009] published 18 new cases and delineated the clinical 
features of this syndrome in great detail. Nicolaides-
Baraitser syndrome is characterized by severe intellectual 
disability with absent or limited speech, short attention 
span, autism spectrum disorder, variable seizures, short 
stature, sparse hair, prominent finger joints, and distinct 
facial features, but it is very likely under-diagnosed since 
so far only 26 patients have been reported [Nicolaides and 
Baraitser, 1993; Krajewska-Walasek et al., 1996; Morin et 
al., 2003; Witters and Fryns, 2003; Castori et al., 2008; 
Sousa et al., 2009; Gana et al., 2011]. Until now, inheri-
tance and underlying genetic cause were unknown, but 
because most patients were sporadic, autosomal domi-
nant new mutations were suspected. Indeed, mutations in 
 SMARCA2 were identified as the underlying cause of 
Nicolaides-Baraitser syndrome by whole exome sequenc-
ing and presented at the 12th International Congress of 
Human Genetics [Van Houdt et al., 2011].
 Of note, our patient with the intragenic deletion ap-
pears to be more severely intellectually disabled than the 
2 patients with missense mutations in the helicase do-
main. Whether this might represent a possible genotype-
phenotype correlation is currently unclear due to our 
limited number of molecularly confirmed patients and as 
all of our 3 patients fit into the described clinical spec-
trum of Nicolaides-Baraitser syndrome. In this context, 
A B
C
 Fig. 2. Identified defects in  SMARCA2 .  A Affymetrix 6.0 Array 
data of patient 1 and his parents showing an intragenic de novo 
deletion of 32 kb within the  SMARCA2 gene at 9p24.3. The first 
and last deleted probes as indicated by the array were 
SNP_A-8705668 (hg18: chr9: 2,079,813) and SNP_A-8601038 
(hg18: chr9: 2,111,371).  B Conservation of the amino acid posi-
tions 1132 and 1188 affected by the missense mutations found in 
patients 2 and 3.  C Schematic drawing of the  SMARCA2 gene with 
localization of the deletion and the 2 missense mutations. Exons 
are color-coded for encoded domains (according to PROSITE, 
http://prosite.expasy.org/). HSA: helicase-SANT-associated do-
main; HEL-ATP-bind: helicase domain with ATP binding func-
tion; Hel-C-term: C-terminal helicase domain; Bromo: bromo-
domain; exon 1 and parts of exon 34 are non-coding (gray). 
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Table 1. Clinical details of patients with Nicolaides-Baraitser syndrome
Patient 1 Patient 2 Patient 3 Published patients
(n = 26)a
SMARCA2 aberration in-frame deletion p.Ala1188Glu p.Gly1132Asp not known
Sex m m m 13 f + 13 m
Age 3 years 7 months 8 years 8 months 9 years 3–32 years
Birth measurements
Weight 3,145 g (25th ct.) 2,890 g (10th ct.) 2,370 g (10th ct.) 11/25 <3rd ct.
Length 52 cm (50th ct.) 49 cm (10th ct.) 45 cm (10th ct.) 8/17 <3rd ct.
OFC 35 cm (25th ct.) 32.5 cm (<3rd ct.) 32 cm (10–25th ct.) 5/17 <3rd ct.
Growth
Height 85 cm (<3rd ct.) 124.5 cm (3rd ct.) 124.5 cm (5th ct.) 15/26 <3rd ct.
Weight 11 kg (<3rd ct.) 23.8 kg (3rd–10th ct.) 20.6 kg (2nd ct.) 16/24 <3rd ct.
OFC 47.5 cm (<3rd ct.) 50.5 cm (<3rd ct.) 52 cm (23rd ct.) 22/26 <3rd ct.
Developmental delay, ID severe severe borderline, IQ = 74 25/26 moderate to severe,
1/26 mild
Age of sitting, months 13 6 10 6–18
Age of walking, months 30 13 19 10–no
Speech, age of first words absent mainly single words,
18 months
good verbal skills,
2 years
13/26 absent
Regression – – – 4/26
Autism, autistic traits +, not formally tested +, formally tested –, formally tested some, 2/2 formally tested
Behavioral anomalies short attention span short attention span short attention span ?
Seizures, age of onset +, 3 years 4 months +, 18 months +, 7 years 18/26
Sparse hair + + + 25/26
Triangular face + + + 22/23
Palpebral fissures down
slant + + + 8/25
Long eyelashes + – + 12/23
Long philtrum +  8 + 22/26
Thin upper lip + + + 22/26
Cryptorchism – – + 8/13
Hernias + – + 6/26
Prominent IP joints + – + 20/26
Broad distal phalanges + – + 18/26
Bone age n.d. n.d. delayed 4/17 advanced, 
8/17 delayed
Cardiac defect aortic coarctation – – 3/26
Skin anomalies eczema, wrinkling – wrinkling, ichthyosis 
(father also), warts 
8/26 eczema,
14/26 wrinkling
Other anomalies neonatal feeding difficul-
ties, muscular hypotonia, 
sandal gaps
neonatal mild feeding 
difficulties, sandal gaps
fetal finger pads, super-
numerary interphalan-
geal creases, short lingual 
frenum, hallux valgus, 
sandal gaps, ataxic gait
14/22 fetal finger pads, 
15/23 sandal gaps
ct. = Centiles; ID = intellectual disability; IP = interphalangeal; n.d. = not determined; OFC = occipito-frontal head circumference.
a Twenty-three cases described by Sousa et al. [2009] and summarizing all published patients [Nicolaides and Baraitser, 1993;
Krajewska-Walasek et al., 1996; Morin et al., 2003; Witters and Fryns, 2003; Sousa et al., 2009] plus 3 further published cases [Cas-
tori et al., 2008; Gana et al., 2011].
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it is interesting that sparse hair as a hallmark of Nico-
laides-Baraitser syndrome is not mentioned in any of the 
DECIPHER patients with 9 large deletions and 4 large 
duplications including the  SMARCA2 gene for which 
clinical descriptions are provided. This further supports 
a specific role of the C-terminal helicase domain for the 
distinct phenotype of Nicolaides-Baraitser syndrome.
 Twenty-five of 26 published patients with Nicolaides-
Baraitser syndrome [Nicolaides and Baraitser, 1993; Kra-
jewska-Walasek et al., 1996; Morin et al., 2003; Witters 
and Fryns, 2003; Castori et al., 2008; Sousa et al., 2009; 
Gana et al., 2011] as well as our patients 1 and 2 showed 
moderate to severe mental retardation; therefore, the 
finding of borderline IQ in patient 3 seems rather excep-
tional. Of note, behavioral anomalies with short attention 
span and/or autistic features were observed in all of our 
patients and specifically reported by Gana et al. [2011]
in 2 patients, thus possibly representing a so far under-
recognized aspect of Nicolaides-Baraitser syndrome. 
Though a role of SMARCA2 and the SWI/SNF complex 
in cancer is supposed [Reisman et al., 2009], malignancies 
have not been reported in any of the patients with Nico-
laides-Baraitser syndrome so far.
 Individual patients with defects in either  SMARCA2 
or  ARID1B show clinical overlap regarding aspects like 
(mild) short stature and certain facial dysmorphism such 
as downslanting palpebral fissures or thin upper lip. In-
tellectual disability is variable in both conditions but 
ranging predominantly from moderate to severe. The 
role of both genes in the same chromatin remodeling 
complex might explain these clinical similarities. How-
ever, the phenotype in patients with  SMARCA2 defects 
seems to be far more distinct, whereas  ARID1B haploin-
sufficiency results in a more variable and less recogniz-
able phenotype [Halgren et al., 2011; Hoyer et al., in press]. 
In addition, our  SMARCA2 mutation-positive patients 
and the majority of published Nicolaides-Baraitser syn-
drome patients [Sousa et al., 2009; Gana et al., 2011] had 
epilepsy, while in patients with  ARID1B haploinsufficien-
cy seizures occur only rarely.
 In conclusion, molecular karyotyping enabled us to 
identify de novo defects of the C-terminal helicase do-
main of  SMARCA2 in patients with Nicolaides-Baraitser 
syndrome. In addition, we extend the phenotypic spec-
trum to include borderline intelligence.
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